logo

For the Inventor, By the Inventor

Green Oaks, IL, United States of America

Jih-Hua Liu

This inventor holds 14 USPTO granted patents, plus 11 CIPO patents. Top assignee: Abbott Laboratories Corporation. Active years: 1998-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jih-Hua Liu. Retrieved from https://idiyas.com/inventor/jih-hua-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14

% Patents Active = 92.9

 

Average Co-Inventor Count = 3.4

ph-index = 9

Forward Citations = 185(Granted Patents)


Location History:

  • Green Oaks, IL (US) (1998 - 2006)
  • Greek Oaks, IL (US) (2001 - 2011)

Company Filing History:

goldMedal14 out of 4,188 
 
Abbott Laboratories Corporation
 patents

Years Active: 1998-2011

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 7968707 - Retroviral protease inhibiting compounds (2011-06-28),
2. RE39383 - Process for 6-O-alkylation of erythromycin derivatives (2006-11-06),
3. 6627743 - 6-O-methylerythromycin A crystal form III (2003-09-30),
4. 6472529 - Retroviral protease inhibiting compounds (2002-10-29),
5. 6313296 - Retroviral protease inhibiting compounds (2001-11-06),
6. 6194387 - 6-O-aklyl erythromycin B oxime (2001-02-27),
7. 5945405 - Crystal form O of clarithromycin (1999-08-31),
8. 5932710 - Process for preparing 6-O-alkyl-9-oxime erythromycin B (1999-08-03),
9. 5919916 - 6-O-alkyl derivatives of erythronolide B (1999-07-06),
10. 5872229 - Process for 6-O-alkylation of erythromycin derivatives (1999-02-16),
11. 5858986 - Crystal form I of clarithromycin (1999-01-12),
12. 5844105 - Preparation of crystal form II of clarithromycin (1998-12-01),
13. 5756473 - 6-O-methyl erythromycin D and process for making (1998-05-26),
14. 5719272 - 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives (1998-02-17),

Title: **Innovations by Jih-Hua Liu: A Trailblazer in HIV Research**

Introduction

Jih-Hua Liu is a prominent inventor based in Green Oaks, IL, known for his significant contributions to the field of biomedical innovations. With an impressive portfolio of 14 patents, Liu has made remarkable strides in the development of therapeutic agents, particularly in the fight against HIV infection.

Latest Patents

Among his latest patents, Liu has developed innovative compounds for inhibiting HIV protease activity. One of his standout inventions is a compound formula specifically designed as an HIV protease inhibitor, alongside methods and compositions aimed at inhibiting HIV infection. Additionally, he has patented a process for the 6-O-alkylation of erythromycin derivatives, which involves a meticulous procedure for preparing 6-O-alkyl erythromycin compounds. This method requires a reaction with an alkylating reagent under the influence of both a strong alkali metal base and a weak organic amino base, performed in a suitable polar aprotic solvent.

Career Highlights

Jih-Hua Liu has significantly contributed to Abbott Laboratories Corporation, where his research efforts have driven innovations in medical science. His dedication to advancing biomedical research has not only propelled his career but also enhanced the company's position as a leader in healthcare solutions.

Collaborations

Liu has had the opportunity to collaborate with notable professionals in his field, including David A. Riley and Stephen H. Montgomery. These partnerships have allowed for the exchange of ideas and strategies that have proven indispensable in the development of Liu's innovative inventions.

Conclusion

Jih-Hua Liu is a distinguished inventor whose work is making a profound impact in the realm of HIV research and pharmaceutical innovation. His commitment to advancing medical science through his patents and collaborations positions him as a key figure in the ongoing battle against HIV infection. Through his contributions, Liu continues to inspire future generations of inventors and researchers in the biomedical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…